-
Ruxolitinib
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Ruxolitinib Myelofibrosis Novartis Julaị 6, 2024 -
Crisaborole
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Crisaborole Atopic dermatitis na eczema Pfizer Ọnwa Isii 11, 2026 -
Vericiguat
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Vericiguat Obi mgbawa Bayer na MSD Mee.Ọktoba 24, 2031 -
Abrocitinib
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Abrocitinib Atopic dermatitis Pfizer Febụwarị 11, 2034 -
Rimegepant
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Rimegepant Isi ọwụwa migraine Biohaven Febụwarị 22, 2031 -
Elagolix 834153-87-6
Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis N'ime ụlọ -
Relugolix 737789-87-6
Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Antineoplastic N'ime ụlọ -
Venetoclax 1257044-40-8
Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US) Venetoclax 1257044-40-8 CLL Abvie Ọnwa Isii 27,2031 -
Velpatasvir (PVP)
Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP Velpatasvir (PVP) HCV N'ime ụlọ √ -
Thalidomide
Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP Thalidomide Ọgwụ Oncology USP/EP -
Ticagrelor
Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP Ticagrelor Ọgwụ mgbochi N'ime ụlọ 28984 √